recarbrio
merck sharp & dohme b.v. - imipenem einhýdrat, cílastatín járn, relebactam einhýdrat - gramm-neikvæð bakteríusýkingum - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 og 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 og 5. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.
clindamycin eql pharma hart hylki 150 mg
eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 150 mg
cefotaxim navamedic (cefotaxim villerton) stungulyfsstofn, lausn 1 g
navamedic asa - cefotaximum natríum - stungulyfsstofn, lausn - 1 g
clindamycin eql pharma hart hylki 300 mg
eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 300 mg
dalacin hart hylki 150 mg
pfizer aps - clindamycinum hýdróklóríð - hart hylki - 150 mg
dalacin hart hylki 300 mg
pfizer aps - clindamycinum hýdróklóríð - hart hylki - 300 mg
dalacin stungulyf, lausn 150 mg/ml
pfizer aps - clindamycinum fosfat - stungulyf, lausn - 150 mg/ml
amlodipin bluefish tafla 10 mg
bluefish pharmaceuticals ab - amlodipinum besýlat - tafla - 10 mg
amlodipine vitabalans tafla 10 mg
vitabalans oy - amlodipinum besýlat - tafla - 10 mg
amlodipin bluefish tafla 5 mg
bluefish pharmaceuticals ab - amlodipinum besýlat - tafla - 5 mg